Table 1 Baseline clinical characteristics of 986 patients with Subarachnoid hemorrhage Between the development group and the validation group
From: A dynamic online nomogram for predicting death in hospital after aneurysmal subarachnoid hemorrhage
Variable | Development (n = 687) | Validation (n = 299) |
|---|---|---|
Gender | 265 (38.57%) | 117 (39.13%) |
Age, years | 58 (50–65) | 60 (51–66) |
Level on GCS score | ||
 Mild (13–15 points) | 455 (66.23%) | 143 (47.83%) |
 Moderate (9–12 points) | 94 (13.68%) | 72 (24.08%) |
 Severe (3–8 points) | 138 (20.09%) | 84 (28.09%) |
Hunt–Hess grade | ||
 I | 137 (19.94%) | 42 (14.05%) |
 II | 131 (19.07%) | 85 (28.43%) |
 III | 266 (38.72%) | 90 (30.10%) |
 IV | 130 (18.92%) | 63 (21.07%) |
 V | 23 (3.35%) | 19 (6.35%) |
mFS grade | ||
 0 | 3 (0.44%) | 4 (1.34%) |
 I | 107 (15.57%) | 24 (8.03%) |
 II | 347 (50.51%) | 146 (48.83%) |
 III | 138 (20.09%) | 81 (27.09%) |
 IV | 92 (13.39%) | 44 (14.72%) |
 NIHSS score | 2 (0–13) | 4 (1–13) |
Hypertension | 270 (39.30%) | 150 (50.17%) |
MAP, mmHg | 136 (120–153) | 111 (101–124) |
Diabetes | 49(7.13%) | 19 (6.35%) |
Smoking | 44 (6.40%) | 22 (7.36%) |
Drink abuse | 34 (4.95%) | 22 (7.36%) |
Blood glucose | 8.40 (7.00–10.79) | 8.74 (7.30–10.57) |
Serum calcium level | 2.27 (2.18–2.36) | 2.17 (2.08–2.24) |
Leukocyte count | 13.84 (10.67–17.01) | 13.50 (10.75–16.63) |
Neutrophil count | 11.61 (8.25–14.64) | 11.08 (7.96–14.01) |
Lymphocyte count | 1.36 (0.91–2.00) | 1.58 (0.98–2.28) |
Monocyte count | 0.56 (0.38–0.78) | 0.64 (0.42–0.89) |
Platelet count | 236 (197–275) | 239 (201–289) |
NLR | 8.81 (4.98–14.03) | 7.49 (3.77–12.06) |
MLR | 0.38 (0.26–0.58) | 0.40 (0.25–0.64) |
PLR | 169.52 (115.19–254.10) | 152.35 (100.45–229.63) |
NWR | 0.85 (0.78–0.90) | 0.82 (0.73–0.88) |
MNM | 5.70 (3.25–10.21) | 6.72 (3.71–11.15) |
mRS (3–6 points) | 264 (38.43%) | 117 (39.13%) |
Death | 72 (10.48%) | 31 (10.37%) |